Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean M Devlin

Showing results (111-120 of 174) with videos related to

Pageof 18
Sort By:
Blood Advances|February 22, 2020
Comparing CAR T-cell toxicity grading systems: application of the ASTCT grading system and implications for managementMartina Pennisi, Tania Jain, Bianca D Santomasso, et al.
Blood Advances|August 12, 2020
Hematopoietic recovery in patients receiving chimeric antigen receptor T-cell therapy for hematologic malignanciesTania Jain, Andrea Knezevic, Martina Pennisi, et al.
Blood|August 15, 2022
Preservation of the fecal microbiome is associated with reduced severity of graft-versus-host diseaseMarina Burgos da Silva, Doris M Ponce, Anqi Dai, et al.
British Journal of Haematology|August 24, 2023
The Simplified Comorbidity Index predicts non-relapse mortality in reduced-intensity conditioning allogeneic haematopoietic cell transplantationShlomo Elias, Samantha Brown, Sean M Devlin, et al.
Blood Advances|July 31, 2023
Identifying an optimal fludarabine exposure for improved outcomes after axi-cel therapy for aggressive B-cell non-Hodgkin lymphomaMichael Scordo, Jessica R Flynn, Mithat Gonen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 23, 2017
The Impact of Toxicities on First-Year Outcomes after Ex Vivo CD34<sup>+</sup>-Selected Allogeneic Hematopoietic Cell Transplantation in Adults with Hematologic MalignanciesSatyajit Kosuri, Diego Adrianzen Herrera, Michael Scordo, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 13, 2018
Allogeneic Stem Cell Transplantation for Advanced Myelodysplastic Syndrome: Comparison of Outcomes between CD34<sup>+</sup> Selected and Unmodified Hematopoietic Stem Cell TransplantationRoni Tamari, Betul Oran, Patrick Hilden, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 6, 2017
Effects of Late Toxicities on Outcomes in Long-Term Survivors of Ex-Vivo CD34<sup>+</sup>-Selected Allogeneic Hematopoietic Cell TransplantationMichael Scordo, Gunjan L Shah, Satyajit Kosuri, et al.
Blood|January 14, 2017
Determinants of fatal bleeding during induction therapy for acute promyelocytic leukemia in the ATRA eraSimon Mantha, Debra A Goldman, Sean M Devlin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 5, 2015
High Disease-Free Survival with Enhanced Protection against Relapse after Double-Unit Cord Blood Transplantation When Compared with T Cell-Depleted Unrelated Donor Transplantation in Patients with Acute Leukemia and Chronic Myelogenous LeukemiaDoris M Ponce, Patrick Hilden, Sean M Devlin, et al.
Pageof 18

Showing results (111-120 of 174) with videos related to

Sort By:
Pageof 18
Blood Advances|February 22, 2020
Comparing CAR T-cell toxicity grading systems: application of the ASTCT grading system and implications for managementMartina Pennisi, Tania Jain, Bianca D Santomasso, et al.
Blood Advances|August 12, 2020
Hematopoietic recovery in patients receiving chimeric antigen receptor T-cell therapy for hematologic malignanciesTania Jain, Andrea Knezevic, Martina Pennisi, et al.
Blood|August 15, 2022
Preservation of the fecal microbiome is associated with reduced severity of graft-versus-host diseaseMarina Burgos da Silva, Doris M Ponce, Anqi Dai, et al.
British Journal of Haematology|August 24, 2023
The Simplified Comorbidity Index predicts non-relapse mortality in reduced-intensity conditioning allogeneic haematopoietic cell transplantationShlomo Elias, Samantha Brown, Sean M Devlin, et al.
Blood Advances|July 31, 2023
Identifying an optimal fludarabine exposure for improved outcomes after axi-cel therapy for aggressive B-cell non-Hodgkin lymphomaMichael Scordo, Jessica R Flynn, Mithat Gonen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 23, 2017
The Impact of Toxicities on First-Year Outcomes after Ex Vivo CD34<sup>+</sup>-Selected Allogeneic Hematopoietic Cell Transplantation in Adults with Hematologic MalignanciesSatyajit Kosuri, Diego Adrianzen Herrera, Michael Scordo, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 13, 2018
Allogeneic Stem Cell Transplantation for Advanced Myelodysplastic Syndrome: Comparison of Outcomes between CD34<sup>+</sup> Selected and Unmodified Hematopoietic Stem Cell TransplantationRoni Tamari, Betul Oran, Patrick Hilden, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 6, 2017
Effects of Late Toxicities on Outcomes in Long-Term Survivors of Ex-Vivo CD34<sup>+</sup>-Selected Allogeneic Hematopoietic Cell TransplantationMichael Scordo, Gunjan L Shah, Satyajit Kosuri, et al.
Blood|January 14, 2017
Determinants of fatal bleeding during induction therapy for acute promyelocytic leukemia in the ATRA eraSimon Mantha, Debra A Goldman, Sean M Devlin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 5, 2015
High Disease-Free Survival with Enhanced Protection against Relapse after Double-Unit Cord Blood Transplantation When Compared with T Cell-Depleted Unrelated Donor Transplantation in Patients with Acute Leukemia and Chronic Myelogenous LeukemiaDoris M Ponce, Patrick Hilden, Sean M Devlin, et al.
Pageof 18